11 results
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
Equianalgesic Chart - Agents ... #Pain #Pharmacology ... Equianalgesics #Conversion ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Non-Opioid Analgesics - Agents ... #Pain #Pharmacology ... #Medications #Doses ... #Dosing #Table ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Muscle Relaxants - Agents ... #Pain #Pharmacology ... #Medications #Doses ... #Dosing #Table ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
Medications: Agent ... , Initiation Dose ... Management #Pain #Pharmacology ... #Dosing #Table ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Distribution, Agents ... and Dosing Table ... Management #Pain #Pharmacology ... #Medications #Doses ... #Dosing #Table
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
Nebulized Medications- Agents ... #Pain #Pharmacology ... #Medications #Doses ... #Dosing #Table ... #PAMI
Angiotensin Receptor Blockers 
Recommended Dose Conversions 

Valsartan 
Irbesartan 
Losartan 
Olmesartan 
Telmisartan 
Candesartan 
Azilsartan 
Eprosartan 

A few
Conversions ... initiating an ARB ... Receptor #Blockers #ARB ... #Conversion #Table ... #Dosing #Pharmacology
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING:
TOOL FOR SWITCHING BETWEEN AGENTS IN CANADA
The information provided is intended
) DOSING: TOOL ... Doses should be ... ReceptorBlocker #Pharmacology ... #Conversion #Switching ... #Equivalent #Table
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
phosphate binding agents ... since they are ... not able to effectively ... Note not listed are ... #Dosing #Pharmacology
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... Switching between oral agents ... of patients who are ... the timing and dosing ... ticagrelor #prasugrel #pharmacology